Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Cost of Revenue: 2022-2024

Historic Cost of Revenue for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $19.1 million.

  • Arcutis Biotherapeutics' Cost of Revenue rose 57.82% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 120.55%. This contributed to the annual value of $19.1 million for FY2024, which is 283.56% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Cost of Revenue stood at $19.1 million for FY2024, which was up 283.56% from $5.0 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Cost of Revenue registered a high of $19.1 million during FY2024, and its lowest value of $754,000 during FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' Cost of Revenue averaged around $8.3 million, with its median value being $5.0 million (2023).
  • Data for Arcutis Biotherapeutics' Cost of Revenue shows a peak YoY skyrocketed of 561.41% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Arcutis Biotherapeutics' Cost of Revenue stood at $754,000 in 2022, then skyrocketed by 561.41% to $5.0 million in 2023, then spiked by 283.56% to $19.1 million in 2024.